MCM
LMAT icon

Massar Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Massar Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,080
Closed -$284K – 141
2024
Q4 		$284K Buy
+3,080
New +$296K 0.32% 46

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Massar Capital Management's LMAT Position: Q1 2025 in Review

Massar Capital Management sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 3,080 shares — an estimated $284K sold.

Massar Capital Management first reported a position in LMAT in Q4 2024 and held it in 1 quarter. The position peaked at $284K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Massar Capital Management reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Massar Capital Management sold 3,080 LeMaitre Vascular shares in Q1 2025, an estimated $284K.
  • Massar Capital Management first reported a position in LeMaitre Vascular in Q4 2024 and held it in 1 quarter.
  • Massar Capital Management's LeMaitre Vascular position peaked at $284K in Q4 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Massar Capital Management's 13F filing for Q1 2025, filed 15 May 2025.